Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Riveiro Barciela, Mar ^a   Buti, María ^a   Homs, María ^a   Campos Varela, Isabel ^a   Cantarell, Carmen ^a   Crespo, Manuel ^a   Castells, Lluís ^a   Tabernero, David ^a   Quer, Josep ^a   Esteban, Rafael ^a   Rodriguez Frías, Francisco ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; HEPATITIS ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS E; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RISK FACTOR; SEROPREVALENCE; ADVERSE EFFECTS; BLOOD; COMPLICATION; HEPATITIS E VIRUS; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; SPAIN;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SPAIN;

EID: 84904917931     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103028     Document Type: Article

References (53)

1. Purcell RH, Emerson SU (2008) Hepatitis E: an emerging awareness of an old disease. J Hepatol 48: 494-503.
2. Peron JM, Dalton H, Izopet J, Kamar N (2011) Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? J Hepatol 54: 1323-1324; author reply 1324-1325.
3. Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, et al. (2008) Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 20: 784-790.
4. Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, et al. (2008) Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 358: 811-817. (Pubitemid 351281642)
5. Matsubayashi K, Nagaoka Y, Sakata H, Sato S, Fukai K, et al. (2004) Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 44: 934-940. (Pubitemid 38738426)
6. Mitsui T, Tsukamoto Y, Yamazaki C, Masuko K, Tsuda F, et al. (2004) Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol 74: 563-572. (Pubitemid 39426097)
7. Boxall E, Herborn A, Kochethu G, Pratt G, Adams D, et al. (2006) Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med 16: 79-83. (Pubitemid 43935063)
8. Colson P, Coze C, Gallian P, Henry M, De Micco P, et al. (2007) Transfusion-associated hepatitis E, France. Emerg Infect Dis 13: 648-649.
9. Matsubayashi K, Kang JH, Sakata H, Takahashi K, Shindo M, et al. (2008) A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 48: 1368-1375.
10. Kimura Y, Gotoh A, Katagiri S, Hoshi Y, Uchida S, et al. (2014) Transfusion-transmitted hepatitis E in a patient with myelodysplastic syndromes. Blood Transfus 12: 103-106.
11. Haim-Boukobza S, Ferey MP, Vetillard AL, Jeblaoui A, Pelissier E, et al. (2012) Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J Hepatol 57: 1374-1378.
12. Cleland A, Smith L, Crossan C, Blatchford O, Dalton HR, et al. (2013) Hepatitis E virus in Scottish blood donors. Vox Sang 105: 283-289.
13. Mansuy JM, Bendall R, Legrand-Abravanel F, Saune K, Miedouge M, et al. (2011) Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 17: 2309-2312.
14. Drobeniuc J, Meng J, Reuter G, Greene-Montfort T, Khudyakova N, et al. (2010) Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 51: e24-27.
15. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H (2010) A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 82: 799-805.
16. Renou C, Lafeuillade A, Cadranel JF, Pavio N, Pariente A, et al. (2010) Hepatitis E virus in HIV-infected patients. AIDS 24: 1493-1499.
17. Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, et al. (2010) Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 16: 74-82.
18. Haagsma EB, Niesters HG, van den Berg AP, Riezebos-Brilman A, Porte RJ, et al. (2009) Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 15: 1225-1228.
19. Legrand-Abravanel F, Kamar N, Sandres-Saune K, Lhomme S, Mansuy JM, et al. (2011) Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 17: 30-37.
20. Harrison A, Scobie L, Crossan C, Parry R, Johnston P, et al. (2013) Hepatitis E seroprevalence in recipients of renal transplants or haemodialysis in southwest England: a case-control study. J Med Virol 85: 266-271.
21. Mateos-Lindemann ML, Diez-Aguilar M, Galdamez AL, Galan JC, Moreno A, et al. (2014) Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain. J Med Virol 86: 71-74.
22. Keane F, Gompels M, Bendall R, Drayton R, Jennings L, et al. (2012) Hepatitis E virus coinfection in patients with HIV infection. HIV Med 13: 83-88.
23. Versluis J, Pas SD, Agteresch HJ, de Man RA, Maaskant J, et al. (2013) Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood 122: 1079-1086.
24. Pischke S, Stiefel P, Franz B, Bremer B, Suneetha PV, et al. (2012) Chronic hepatitis e in heart transplant recipients. Am J Transplant 12: 3128-3133.
25. Pas SD, de Man RA, Mulders C, Balk AH, van Hal PT, et al. (2012) Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis 18: 869-872.
26. Buti M, Cabrera C, Jardi R, Castells L, Esteban R (2010) Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection? Liver Transpl 16: 106-107; author reply 108.
27. Hamid SS, Atiq M, Shehzad F, Yasmeen A, Nissa T, et al. (2002) Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology 36: 474-478. (Pubitemid 34810369)
28. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, et al. (2009) Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 200: 48-56.
29. Pischke S, Gisa A, Suneetha PV, Wiegand SB, Taubert R, et al. (2014) Increased HEV Seroprevalence in Patients with Autoimmune Hepatitis. PLoS One 9: e85330.
30. Jardi R, Crespo M, Homs M, van den Eynde E, Girones R, et al. (2012) HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain. HIV Med 13: 379-383.
31. Buti M, Dominguez A, Plans P, Jardi R, Schaper M, et al. (2006) Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain. Clin Vaccine Immunol 13: 1328-1332. (Pubitemid 46086898)
32. Buti M, Plans P, Dominguez A, Jardi R, Rodriguez Frias F, et al. (2008) Prevalence of hepatitis E virus infection in children in the northeast of Spain. Clin Vaccine Immunol 15: 732-734. (Pubitemid 351967042)
33. Clemente-Casares P, Pina S, Buti M, Jardi R, MartIn M, et al. (2003) Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis 9: 448-454. (Pubitemid 37070411)
34. Buti M, Clemente-Casares P, Jardi R, Formiga-Cruz M, Schaper M, et al. (2004) Sporadic cases of acute autochthonous hepatitis E in Spain. J Hepatol 41: 126-131. (Pubitemid 39005163)
35. Lavanchy D, Morel B, Frei PC (1994) Seroprevalence of hepatitis E virus in Switzerland. Lancet 344: 747-748.
36. Boutrouille A, Bakkali-Kassimi L, Cruciere C, Pavio N (2007) Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol 45: 2009-2010. (Pubitemid 46933947)
37. Abravanel F, Chapuy-Regaud S, Lhomme S, Miedouge M, Peron JM, et al. (2013) Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J Clin Virol 58: 624-628.
38. Kumar Acharya S, Kumar Sharma P, Singh R, Kumar Mohanty S, Madan K, et al. (2007) Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol 46: 387-394. (Pubitemid 46185699)
39. Goyal R, Kumar A, Panda SK, Paul SB, Acharya SK (2012) Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report. Antivir Ther 17: 1091-1096.
40. Chuang WL, Liu HW, Chang WY, Chen SC, Hsieh MY, et al. (1991) Natural killer cell activity in patients with liver cirrhosis relative to severity of liver damage. Dig Dis Sci 36: 299-302.
41. Jeong WI, Park O, Suh YG, Byun JS, Park SY, et al. (2011) Suppression of innate immunity (natural killer cell/interferon-gamma) in the advanced stages of liver fibrosis in mice. Hepatology 53: 1342-1351.
42. Chandra V, Kar-Roy A, Kumari S, Mayor S, Jameel S (2008) The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response. J Virol 82: 7100-7110. (Pubitemid 351977728)
43. Surjit M, Oberoi R, Kumar R, Lal SK (2006) Enhanced alpha1 microglobulin secretion from Hepatitis E virus ORF3-expressing human hepatoma cells is mediated by the tumor susceptibility gene 101. J Biol Chem 281: 8135-8142. (Pubitemid 43847432)
44. Pischke S, Hardtke S, Bode U, Birkner S, Chatzikyrkou C, et al. (2013) Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int 33: 722-726.
45. Riveiro-Barciela M, Minguez B, Girones R, Rodriguez-Frias F, Quer J, et al. (2014) Phylogenetic Demonstration of Hepatitis E Infection Transmitted by Pork Meat Ingestion. J Clin Gastroenterol.
46. Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, et al. (2014) Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 370: 1111-1120.
47. Balayan MS, Fedorova OE, Mikhailov MI, Rytick PG, Eremin VF, et al. (1997) Antibody to hepatitis E virus in HIV-infected individuals and AIDS patients. J Viral Hepat 4: 279-283. (Pubitemid 127733435)
48. Fainboim H, Gonzalez J, Fassio E, Martinez A, Otegui L, et al. (1999) Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study. J Viral Hepat 6: 53-57. (Pubitemid 29077625)
49. Pischke S, Ho H, Urbanek F, Meyer-Olsen D, Suneetha PV, et al. (2010) Hepatitis E in HIV-positive patients in a low-endemic country. J Viral Hepat 17: 598-599.
50. Mateos ML, Camarero C, Lasa E, Teruel JL, Mir N, et al. (1999) Hepatitis E virus: relevance in blood donors and risk groups. Vox Sang 76: 78-80. (Pubitemid 29134691)
51. Maylin S, Stephan R, Molina JM, Peraldi MN, Scieux C, et al. (2012) Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised. J Clin Virol 53: 346-349.
52. Pas SD, Streefkerk RH, Pronk M, de Man RA, Beersma MF, et al. (2013) Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J Clin Virol 58: 629-634.
53. Rossi-Tamisier M, Moal V, Gerolami R, Colson P (2013) Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients. J Clin Virol 56: 62-64.